Irving, Texas-based VHA, Inc., has named the winners of its 2014 Excellence Awards, honoring 13 member hospitals for achievements related to supply chain performance improvement, according to a news release.
Supply Chain
The global continuous glucose monitoring market is expected to be valued at $568.5 million by 2020, growing at a compound annual growth rate of 14.8 percent, according to a Research Beam report.
Earlier this year, the Food and Drug Administration reported that the number of new drug shortages was on the decline. Clearly this is positive news and a reflection of the hard work by multiple parties across the healthcare supply chain…
The U.S. Food and Drug Administration has approved the first DNA test that serves as a primary screening for the human papillomavirus in women ages 25 and older.
The intravenous fluid shortage continues to hinder hospitals nationwide.
Advertisement
Zimmer and Biomet, two leading orthopedic and spine device companies, have agreed to merge in a deal worth almost $13.4 billion.
Zimmer and Biomet announced that their respective boards of directors have approved a definitive agreement, under which Zimmer will acquire Biomet in a transaction valued at approximately $13.35 billion.
The U.S. Food and Drug Administration has approved Sylvant (siltuximab) to treat multicentric Castleman's disease.
The U.S. Food and Drug Administration is requiring warning labels be added to injectable corticosteroids to describe potential serious, adverse neurological events.
Lake Forest, Ill.-based Hospira has voluntarily recalled one lot of 0.25% Marcaine, 10 ml, Single-dose Vial, Preservative Free, due to discolored solution and visible particles embedded in the glass.